AMAlexander Mundinger

Alexander Mundinger

*This is an algorithmically generated author record based on publicly available information.

Alexander Mundinger has a total of 98 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Survey of the Senologic International Society (SIS) on the Use of Preoperative Breast MRI in Early-Stage Breast Cancer: A Global Perspective on Current Practice

    by Alexander Mundinger, Carolin Mundinger, Darius Dian, Thorsten Heilmann, Shigeru Imoto, Atilla Soran, Wendie A Berg, Tolga Ozmen, Mitsuhiro Tozaki, Katja Siegmann-Luz, et al.

    Survey of the Senologic International Society (SIS) on the Use of Preoperative Breast MRI in Early-Stage Breast Cancer: A Global Perspective on Current Practice - European Journal of Breast Health

  • Open Access

    Artificial intelligence in breast oncology

    by Alexander Mundinger

    Artificial intelligence (AI) is based on complex artificial neural networks, characterized by layered network architecture, parallel processing of large data sets and iterative algorithms for processing large data sets. AI-assisted screening studies have demonstrated non-inferior diagnostic performance, reduced human workload by up to 70%, and reduced recall rates by 25% compared to human double reading. Natural language models promise high accuracy in advising on breast cancer prevention (80%), guiding tumor boards for personalized treatment decisions (50–70%), and planning oncoplastic or radiotherapy treatment for standard cases (72%), but AI sometimes produces errors and fails in complex cases. The main technical advantage of AI is that it can perform routine tasks faster and with fewer errors than humans. This is relevant for scheduling, summarizing reports, recording services for billing and quality assurance. The main concerns in healthcare are the quality of training data, the stability of AI systems, cybersecurity, liability and transparency. Currently, human experts still outperform AI in most areas. AI self-correcting algorithms and the alignment of AI constructed goals with human ethics are imperative to prevent patient harm. The ability of AI to uncover hidden patterns in multi-omics, immune regulation and tumor defense, as well as to develop new drugs, will advance the integrative fight against breast cancer.


  • Open Access

    What Changes are Mandatory in Breast Surgery Training? An International Survey and Recommendations of the French Academy of Surgery and the Senologic International Society

    by Tolga Ozmen, Caroline Bouche, Megane Buttignol, Bolivar Arboleda-Osorio, Mauricio Magalhaes Costa, Henry Coudane, Darius Dian, Xishan Hao, Shigeru Imoto, Olivier Jardé, et al.

    What Changes are Mandatory in Breast Surgery Training? An International Survey and Recommendations of the French Academy of Surgery and the Senologic International Society - European Journal of Breast Health


  • Artificial Intelligence in Senology - Where Do We Stand and What Are the Future Horizons?

    by Alexander Mundinger, Carolin Mundinger

    Artificial Intelligence (AI) is defined as the simulation of human intelligence by a digital computer or robotic system and has become a hype in current conversations. A subcategory of AI is deep learning, which is based on complex artificial neural networks that mimic the principles of human synaptic plasticity and layered brain architectures, and uses large-scale data processing. AI -based image analysis in breast screening programmes has shown noninferior sensitivity, reduces workload by up to 70% by pre -selecting normal cases, and reduces recall by 25% compared to human double reading. Natural language programs such as ChatGPT (OpenAI) achieve 80% and higher accuracy in advising and decision making compared to the gold standard: human judgement. This does not yet meet the necessary requirements for medical products in terms of patient safety. The main advantage of AI is that it can perform routine but complex tasks much faster and with fewer errors than humans. The main concerns in healthcare are the stability of AI systems, cybersecurity, liability and transparency. More widespread use of AI could affect human jobs in healthcare and increase technological dependency. AI in senology is just beginning to evolve towards better forms with improved properties. Responsible training of AI systems with meaningful raw data and scientific studies to analyse their performance in the real world are necessary to keep AI on track. To mitigate significant risks, it will be necessary to balance active promotion and development of quality -assured AI systems with careful regulation. AI regulation has only recently included in transnational legal frameworks, as the European Union's AI Act was the first comprehensive legal framework to be published, in December 2023. Unacceptable AI systems will be banned if they are deemed to pose a clear threat to people's fundamental rights. Using AI and combining it with human wisdom, empathy and affection will be the method of choice for further, fruitful development of tomorrow's senology.


  • Current Challenges and Perspectives in Breast Cancer in Elderly Women: The Senologic International Society (SIS) Survey

    by Louise Scheer, Massimo Lodi, Tolga Özmen, Khalid Alghamdi, Stanley Anyanwu, Joshi Birendra, Mohsen Boubnider, Mauricio Costa, Darius Dian, Elisabeth Elder, et al.

    Mammographic screening and management of breast cancer (BC) in elderly women are controversial and continue to be an important health problem. To investigate, through members of the Senologic International Society (SIS), the current global practices in BC in elderly women, highlighting topics of debate and suggesting perspectives. The questionnaire was sent to the SIS network and included 55 questions on definitions of an elderly woman, BC epidemiology, screening, clinical and pathological characteristics, therapeutic management in elderly women, onco-geriatric assessment and perspectives. Twenty-eight respondents from 21 countries and six continents, representing a population of 2.86 billion, completed and submitted the survey. Most respondents considered women 70 years and older to be elderly. In most countries, BC was often diagnosed at an advanced stage compared to younger women, and age-related mortality was high. For this reason, participants recommended that personalized screening be continued in elderly women with a long life expectancy. In addition, this survey highlighted that geriatric frailty assessment tools and comprehensive geriatric evaluations needed to be used more and should be developed to avoid undertreatment. Similarly, multidisciplinary meetings dedicated to elderly women with BC should be encouraged to avoid under- and over-treatment and to increase their participation in clinical trials. Due to increased life expectancy, BC in elderly women will become a more important field in public health. Therefore, screening, personalized treatment, and comprehensive geriatric assessment should be the cornerstones of future practice to avoid the current excess of age-related mortality. This survey described, through members of the SIS, a global picture of current international practices in BC in elderly women.


  • The Senologic International Society Survey on Ductal Carcinoma In Situ: Present and Future

    by Carole Mathelin, Massimo Lodi, Khalid Alghamdi, Bolivar Arboleda-Osorio, Eli Avisar, Stanley Anyanwu, Mohcen Boubnider, Mauricio Maghales Costa, Elisabeth Elder, Tony Elonge, et al.

    Objective: Therapeutic management of ductal carcinoma in situ (DCIS) is heterogeneous among countries worldwide, and some treatment indications are still controversial. To investigate DCIS management in different countries; identify both consensual practices and controversial topics; and survey opinions about the future management of DCIS. Materials and Methods: The Senologic International Society network members participated to an online survey using a questionnaire, between November 2021 and February 2022. Results: Twenty-two responses from 20 different countries showed that organized breast cancer screening programs were present for 87% participants, and DCIS cases represented 13.7% of all breast cancers. Most participants used the grade classification (100%), the morphological classification (78%) and performed immunohistochemistry assays (73%). In case of conservative treatment, the mean re-excision rate was 10.3% and clear margins of mean 2.5 mm were considered healthy. Radical mastectomy rate was 35.5% with a breast reconstruction rate of 53%. Tumor bed boost indications were heterogeneous, and 73% of participants indicated hormone therapy for hormone-positive DCIS. Surgery and radiotherapy omission for some low-risk DCIS were considered by 73% of participants. Multigene assays were used by 43% of participants. Concerning future changes in DCIS management, participants mostly answered surgical de-escalation (48%), radiotherapy de-escalation (35) and/or active surveillance for some cases (22%). Conclusion: This survey provided an overview of the current practices of DCIS management worldwide. It showed that some areas are rather consensual: incidence increases over time, treatment in young women, pathological classifications, definition of healthy margins, the skin-sparing mastectomy and immediate breast reconstruction. However, some topics are still debated and result in heterogeneous practices, such as evolution in the age of diagnosis, the benefit of de-escalation in low-risk DCIS among elderly women, indications for hormone therapy, radiotherapy omission, or multigene assays. Further evidence is needed to reach consensus on these points, and innovative approaches are still under evaluation in clinical trials. The International Senologic Society, by its members, encourages precision medicine and personalized treatments for DCIS, to avoid overtreatment and overdiagnosis, and provide better healthcare to women with DCIS.


  • Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey

    by Carole Mathelin, Shanti Ame, Stanley Anyanwu, Eli Avisar, Wahib Mohcen Boubnider, Katrin Breitling, Hannah Ayettey Anie, José Carlos Conceição, Veronique Dupont, Elisabeth Elder, et al.

    Objective: In early 2020, the spread of coronavirus disease-2019 (COVID-19) led the World Health Organization to declare this disease a pandemic. Initial epidemiological data showed that patients with cancer were at high risk of developing severe forms of COVID-19. National scientific societies published recommendations modifying the patients' breast cancer (BC) management to preserve, in theory, quality oncologic care, avoiding the increased risk of contamination. The Senology International Society (SIS) decided to take an inventory of the actions taken worldwide. This study investigates COVID-19-related changes concerning BC management and analyzes the will to maintain them after the pandemic, evaluating their oncological safety consequences. Materials and Methods: SIS network members participated in an online survey using a questionnaire (Microsoft (R) Forms) from June 15th to July 31st, 2020. Results: Forty-five responses from 24 countries showed that screening programs had been suspended (68%); magnetic resonance imagines were postponed (73%); telemedicine was preferred when possible (71%). Surgeries were postponed: reconstructive (77%), for benign diseases (84%), and in patients with significant comorbidities (66%). Chemotherapy and radiotherapy protocols had been adapted in 28% of patients in both. Exception for telemedicine (34%), these changes in practice should not be continued. Conclusion: The SIS survey showed significant changes in BC's diagnosis and treatment during the first wave of the COVID-19 pandemic, but most of these changes should not be maintained. Indeed, women have fewer severe forms of COVID-19 and are less likely to die than men. The risk of dying from COVID-19 is more related to the presence of comorbidities and age than to BC. Stopping screening and delaying treatment leads to more advanced stages of BC. Only women aged over 65 with BC under treatment and comorbidities require adaptation of their cancer management.


  • Mammasonografie Update

    by A. Mundinger, H. Madjar

    Neue Entwicklungen der Sonografie umfassen die klinische Erprobung der automatisierten 3D-Ultraschallbildgebung, die technische Optimierung moderner Hochfrequenzschallköpfe, die multiparametrische Bildanalyse aus Elastizitäts-, Durchblutungs- und Architekturinformationen und die Integration der Sonografie in Hybridsysteme. Die automatisierte 3D-Ultraschallbildgebung liefert einen 3D-Bilddatensatz, der ähnlich wie CT- oder MR-Volumendatensätze an einer Workstation ausgelesen werden kann. Die Hochfrequenzsonografie ist erforderlich, um kleinste Details wie DCIS oder invasive multifokale Läsionen zu erfassen. Fortschrittliche Technologien wie Compounding, Harmonic Imaging oder die Verminderung von Speckles erhöhen das Signal-Kontrast-Verhältnis. Die vaskuläre Bildgebung und die Elastografie erlauben es, harte oder hypervaskularisierte BI-RADS-US-3-Herde auf BI-RADS-US 4a hochzustufen. New developments in ultrasound encompass 3-D automated US as an adjunct to screening mammography, handheld high frequency transducers in whole breast US, and hybrid systems. High-frequency ultrasound is relevant for assessing small mammographic masses and for preoperative staging to detect accompanying focal or ductal changes due to DCIS or invasive foci and metastatic axillary lymph nodes. Advanced modes as compounding, tissue harmonic imaging and speckle reduction increase the signal to contrast ratio. Doppler techniques and elastography are additional tools to re-categorize BI-RADS 3 vs. 4a lesions, suggesting to upgrade the former if the lesion is stiff or hyper-vascularised.


  • Stichverletzungen der großen Halsgefäße

    by S. Etl, G. Hafer, A. Mundinger

    Berichtet wird über Stichverletzungen der A. carotis communis und V. jugularis interna bei einem 25 jährigen, die notfallmäßig in schwerem hämorrhagischen Schock durch einen Venenpatch erfolgreich versorgt wurden. Milde, rückläufige neurologische Defizite korrelierten in der Magnetresonanztomographie mit Perfusionsstörungen im Stromgebiet der A. cerebri media. Eine Literaturübersicht zeigt, daß der schnellen Rekonstruktion der Strohmbahn gegenüber der Ligatur eindeutig der Vorzug zu geben ist. Ersteres kann in Ausnahmesituationen auch erfolgreich von Chirurgen durchgeführt werden, die nicht routinemäßig Karotischirurgie betreiben, wenn grundsätzliche gefäßchirurgische Techniken beherrscht werden. The case of a 25 year old male with a stab wound of common carotid artery and the internal jugular vein is reported. He was admitted in severe hemorrhagic shock and immediatly treated succesfully by arterial reconstruction by means of a venous patch. Mild, declining neurological deficits correlated in magnetic resonance imaging with disturbances in the perfusion area of the medial cerebral artery. A survey of the literature shows that the fast repair of the carotid artery is clearly to be given preference to ligature. First can be executed successfully in exceptional emergency cases also by non-carotid surgeons, if basic vascular-surgical techniques are controlled.